Previous lung disease and lung cancer risk among women (United States)

Cancer Causes & Control - Tập 11 - Trang 853-858 - 2000
Ross C. Brownson, Michael C.R. Alavanja

Tóm tắt

Objective:The association between previous lung diseases (PLD) and lung cancer risk has not been studied extensively. We conducted a registry-based case–control study to examine the relation between previous lung diseases and lung cancer among women in Missouri. Methods:Incident cases (n = 676) were identified through the Missouri Cancer Registry for the period 1 January 1993 to 31 January 1994. Controls (n = 700) were selected through drivers' license files and Medicare files. Results:Whether analyzing all respondents or in-person interviews only, elevated effect estimates were noted for several types of PLD. Elevated relative risk estimates were shown for chronic bronchitis (odds ratio [OR] = 1.7; 95% confidence interval [CI] = 1.2–2.3), emphysema (OR = 2.7; 95% CI = 1.8–4.2), pneumonia (OR = 1.6; 95% CI = 1.2–2.0), and for all PLDs combined (OR = 1.5; 95% CI = 1.2–1.9). Analysis of only direct interviews did not show a substantial or consistent pattern of change in relative risk estimates. Because PLDs identified close to the time of cancer diagnosis could conceivably be misdiagnosed, resulting from early lung cancer symptoms, we evaluated the effects on risk estimates of a “latency exclusion” of up to threeyears. When these exclusions were taken into account, ORs remained statistically significantly elevated only for emphysema. Conclusion:When earlier epidemiologic findings and underlying biological and genetic factors are taken into account, an association between PLD and lung cancer is plausible.

Từ khóa


Tài liệu tham khảo

Ernster VL (1996) Female lung cancer. Annu Rev Public Health 17: 97–114.

US Dept of Health and Human Services (1989) Reducing the Health Consequences of Smoking-25 Years of Progress: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Public Health Service, Office on Smoking and Health, US Department of Health and Human Services publication 89–8411.

Brownson RC, Alavanja MCR, Caporaso N, Simoes EJ, Chang JC (1998) Epidemiology and prevention of lung cancer in nonsmokers. Epidemiol Rev 20: 218–236.

Gao Y, Blot WJ, Zheng W, et al. (1987) Lung cancer among Chinese women. Int J Cancer 40: 604–609.

Wu-Williams AH, Dai XD, Blot W, et al. (1990) Lung cancer among women in north-east China. Br J Cancer 62: 982–987.

Ger L-P, Hsu W-L, Chen K-T, Chen C-J (1993) Risk factors of lung cancer by histological category in Taiwan. Anticancer Res 13: 1491–1500.

Alavanja MCR, Brownson RC, Boice JD Jr, Hoch E (1992) Preexisting lung disease and lung cancer among non-smoking women. Am J Epidemiol 136: 623–632.

Wu AH, Fontham ETH, Reynolds P, et al. (1995) Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 141: 1023–1032.

Ko Y-C, Lee C-H, Chen M-J, et al. (1997) Risk factors for primary lung cancer among non-smoking women in Taiwan. Int J Epidemiol 26: 24–31.

Mayne ST, Buenconsejo J, Janerich DT (1999) Previous lung disease and risk of lung cancer among men and women nonsmok-ers. Am J Epidemiol 149: 13–20.

Biesalski HK, de Mesquita BB, Chesson A, et al. (1997) Consensus statement on lung cancer. Eur J Cancer Prev 6: 316–322.

Brownson RC, Davis JR, Chang JC, DiLorenzo TM, Keefe TJ, Bagby JR Jr (1989) A study of the accuracy of cancer risk factor information reported to a central registry compared with that obtained by interview. Am J Epidemiol 129: 616–624.

World Health Organization (1982) The World Health Organization Histologic Typing of Lung Tumors, 2nd edn. Am J Clin Pathol 77: 123–136.

Koss LG (1979) Diagnostic Cytology and its Histopathologic Bases, 3rd edn. Philadelphia, PA: Lippincott.

Martin G, Alavanja MCR, Zahm SH. Department of Health and Human Services Epidemiology Research (1989) Data Users Conference Proceedings. LBaltimore, MD: Health Care Finance Administration; HCFA publication no 03293, 181–186.

Alavanja MCR, Brownson RC, Berger E, Lubin J, Modigh C (1996) Avian exposure and the risk of lung cancer in Missouri (USA). Br J Med 313: 1233–1235.

Alavanja MCR, Lubin JH, Mahaffey JA, Brownson RC (1999) Residential radon exposure and risk of lung cancer in Missouri. Am J Public Health 89: 1042–1048.

Swanson CA, Brown CC, Sinha R, Kulldor. M, Brownson RC, Alavanja MC (1997) Dietary fats and lung cancer risk among women: the Missouri Women's Health Study. Cancer Causes Control 8: 883–893.

Weinberg C, Wacholder S (1990) The design and analysis of case-control studies with biased sampling. Biometrics 46: 963–975.

Breslow NE, Day NE (1980) Statistical Methods in Cancer Research, vol. 1: The Analysis of Case-Control Studies. LLyon: International Agency of Research on Cancer, IARC publication 32.

Greenland S (1989) Model and variable selection in epidemiologic analysis. Am J Public Health 79: 340–349.

Tockman MS, Anthonisen NR, Wright EC, et al. (1987) Airways obstruction and the risk for lung cancer. Ann Intern Med 106: 512–518.

McFadden ER Jr, Gilbert IA (1992) Asthma. N Engl J Med 327: 1928–1937.

Kueppers F, Pallat R, Larson RJ (1969) Obstructive lung disease and a1–antitrypsin deficiency gene heterozygosity. Science 165: 899–901.

Cooper DM, Hoeppner VH, Cox DW, Zamel N, Bryan AC, Levinson H (1974) Lung function in a1–antitrypsin heterozygotes (Pi type MZ). Annu Rev Respir Dis 110: 708–715.

Yang P, Wentziaff KA, Katzmann JA, et al. (1999) Alpha1-antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemiol Biomakers Prev 8: 461–465.

Laurila AL, Anitila T, Läärä E, et al. (1997) Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int J Cancer 74: 31–34.

Hahn DL, Dodge RW, Golubiatnikov R (1991) Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 266: 225–230.

Von Hertzen L, Leinonen M, Surcel H-M, Karulamen J, Saikku P (1995) Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with C. pneumoniae. Clin Diagn Lab Immunol 2: 454–457.

Karvonen M, Tuomilehto J, Pitkaniemi J, Naukkarinen A, Saikku P (1994) The importance of smoking for antibodies against Chlamydia pneumoniae seropositivity. Int J Epidemiol 24: 1315–1321.

Ohshima H, Bartsch H (1994) Chronic infection and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 305: 253–264.

Thông tin
Thông tin xuất bản

Cancer Causes & Control

Tập 11

853-858

Thông tin tác giả